1. Multiple drugs
   , 2024, Reactions Weekly CrossRef
2. Brigatinib treatment in a patient with advanced NSCLC with XPO1-ALK fusion: a case report
   Yang Zhang et al, 2025, Front. Oncol. CrossRef